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Abstract 
Background: A microbial cell factory with high yield and productivity are prerequisites for an economically feasible 
bio-based chemical industry. However, cell factories that show a kinetic imbalance between glycolysis and product 
formation pathways are not optimal. Glycolysis activity is highly robust for survival in nature, but is not optimized for 
chemical production.
Results: Here, we propose a novel approach to balance glycolytic activity with the product formation capacity by 
precisely controlling expression level of ptsG (encoded glucose transporter) through UTR engineering. For various het-
erologous pathways with different maximum production rates, e.g., n-butanol, butyrate, and 2,3-butanediol, glycolytic 
fluxes could be successfully modulated to maximize yield and productivity, while minimizing by-product formation in 
Escherichia coli.
Conclusions: These results support the application of this simple method to explore the maximum yield and pro-
ductivity when designing optimal cell factories for value-added products in the fields of metabolic engineering and 
synthetic biology.
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Background
Optimal microbial cell factories are essential to develop 
economically feasible production processes for various 
value-added chemicals from renewable biomass at an 
industrial scale [1]. Therefore, the design of cell factories 
in the fields of metabolic engineering and synthetic biol-
ogy aims to maximize cellular performance in terms of 
yield and productivity. This optimization is particularly 
important for high-volume (and low-value) bulk chemi-
cals and biofuels [2], e.g., n-butanol (an alternative to gas-
oline) [3], butyrate (chemical feedstock for plastics) [4], 
and 2,3-butanediol (for rubbers) [5].
In general, cell factories can be simplified into two 
parts: a carbon utilization pathway, such as glycolysis, 
and a product formation pathway (Fig. 1). Traditionally, 
research in this field has focused on the product-forming 
pathways of interest. Yield can be enhanced by rerouting 
the carbon flux toward the target product by eliminat-
ing endogenous side reactions, and productivity can be 
improved by increasing the catalytic activity of kinetic 
bottlenecks in the product formation pathway [6–8]. 
However, we additionally speculated that the kinetic 
imbalance between glycolysis and product formation 
pathways should be considered in the design principle for 
optimal cell factories to maximize yield and productivity. 
When the maximum catalytic activity of the engineered 
pathway, i.e., the capacity of the product formation path-
way, is lower than the glycolytic activity, additional car-
bon inputs can be wasted as by-products and the yield 
is consequently reduced (Fig. 1, Product A). In contrast, 
if the product formation capacity exceeds the glycolytic 
flux, glycolytic activity can be regarded as the rate-limit-
ing step and increases in activity are necessary to improve 
productivity (Fig. 1, Product B). Pyruvate, for example, is 
a critical intermediate between sugar uptake and prod-
uct formation as a final metabolite of glycolysis in almost 
all organisms [9]. Excess pyruvate, i.e., quantities that 
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exceed the requirement for product formation, is inevi-
tably secreted from the cell [10, 11], causing a substantial 
reduction in yield, whereas a lack of pyruvate limits the 
product formation rate, i.e., reduces productivity (Fig. 1). 
Taken together, a balance between glycolysis and product 
formation is required to construct a microbial cell factory 
with the maximum performance and this can be achieved 
via the precise control of glycolysis to maintain a balance 
with the capacity of the product formation pathway [12, 
13].
However, methods to control the glycolytic flux are not 
well-studied owing to the robustness of native glycolytic 
activity, which is mediated by complex regulatory sys-
tems at many levels, including transcription, translation, 
and the allosteric control of enzymes [14]. Therefore, we 
focused on the carbon uptake system for the artificial 
control of carbon influx and simultaneously attempted to 
detour innate cellular regulatory mechanisms. There are 
several routes to start glycolysis in bacteria. For exam-
ple, the phosphoenolpyruvate (PEP)-dependent sugar 
phosphotransferase system (PTS) that predominantly 
participates in both the transportation and phosphoryla-
tion of glucose. Alternatively, glucose can be internalized 
by a galactose transporter (GalP or MglABC) and subse-
quently phosphorylated by hexokinase to enter glycolysis. 
As such alternative pathways enable to decouple glucose 
transportation and PEP-dependent phosphorylation, 
and therefore the pathways were previously exploited to 
increase precursor availability, such as PEP and free glu-
cose, for the production of aromatic amino acids [15, 16] 
and gluconic acid [17, 18], respectively. Strikingly, how-
ever, the PTS is the most efficient system in terms of 
energetic costs and kinetic parameters for glucose trans-
portation among the routes [19]. The group translocation 
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Fig. 1 Schematic diagram describing the discrepancy in efficiency between glycolysis and the product-forming pathway and the concept of a 
metabolic valve. In the general case, the native  FluxGlycolysis exceeds the engineered  CapacityProduct-forming pathway A (width of pipelines), resulting in the 
leakage of excess carbon as a by-product. In the opposite case, the  CapacityProduct-forming pathway B is enough to cover glycolytic flux; therefore, overall 
production rates are determined by  CapacityGlycolysis. Using a metabolic valve, the glycolytic flux could be tuned down for product A (denoted gage 
as ‘lower’) or amplified for product B (denoted gage as ‘higher’)
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system is composed of non-sugar-specific soluble pro-
teins: the phosphohistidine carrier protein (HPr) and 
the Enzyme I (EI) component (encoded by ptsH and ptsI, 
respectively), the glucose-specific cytoplasmic enzyme 
EIIA  (EIIAGlc, encoded by crr), and the membrane-
bound glucose-specific enzyme IICB  (EIICBGlc, encoded 
by dicistronic ptsG) [19, 20]. Moreover, PTS is primarily 
responsible for the control of glucose uptake in response 
to overflow glycolytic flux (for example, the accumula-
tion of glucose-6-phosphate) via the post-transcriptional 
repression of ptsG as the initial step in glucose import 
[21, 22]. Previous studies revealed that Escherichia coli 
small RNA SgrS is induced under glucose phosphate 
stress and it causes the translational repression and the 
RNaseE-dependent rapid degradation of the ptsG mRNA 
[23] by binding to the 5′-end of mRNA [24, 25]. More 
recent work characterized a minimal base-pairing region 
between SgrS and ptsG mRNA that 14nt base-pairing 
region including Shine–Dalgarno (SD) sequence of the 
target mRNA is sufficient to inhibit ptsG translation 
(Fig. 2) [26].
In this study, we examined the potential use of ptsG 
as a simple method to control the overall glycolytic flux 
simply by designing a synthetic 5′-untranslated region 
(UTR). UTR engineering is a suitable approach for con-
trolling expression of target genes as well as for elimi-
nating the unpredictable regulatory elements within the 
metabolic pathway [27]. Furthermore, we demonstrated 
the importance of rebalancing glycolytic flux depend-
ing on the efficiency of product formation pathways 
using recombinant E. coli strains producing n-butanol, 
butyrate, or 2,3-butanediol as model cell factories. Our 
approach enables the maximization of both yield and 
productivity in the construction of microbial cell facto-
ries by simply optimizing glycolytic flux; accordingly, it 
has broad applications for the cost-effective production 
of various chemicals and fuels.
Methods
Reagents, bacterial strains, and plasmids
A list of E. coli bacterial strains and plasmids used in this 
study is presented in Additional file 1: Table S1. Oligonu-
cleotides used in this study were synthesized by Macro-
gen (Daejeon, Korea) and are listed in Additional file 1: 
Table  S2. The rpsL-neo template DNA was obtained 
using the Counter-selection BAC Modification Kit (Gene 
Bridges, Heidelberg, Germany). Phusion DNA Polymer-
ase and restriction endonuclease were supplied by New 
England Biolabs (Ipswich, MA, USA), and T4 DNA 
ligase was purchased from Takara Bio Inc. (Shiga, Japan). 
Genomic DNA and propagated plasmids were prepared 
using a GeneAll Exgene™ Cell SV Kit (GeneAll Bio-
technology, Seoul, Korea) and an AccuPrep Nano-Plus 
Plasmid Mini Extraction Kit (Bioneer, Daejeon, Korea), 
respectively. Restriction enzyme-digested products were 
purified using a GeneAll Expin™ Gel SV Kit (GeneAll 
Biotechnology). All cell culture reagents were purchased 
from BD Biosciences (Sparks, MD, USA), and all other 
chemicals used in this study were purchased from Sigma 
(St. Louis, MO, USA), unless otherwise indicated.
Chromosomal modifications, including deletions and 
substitutions of the 5′-UTR of ptsG, were performed 
using the Red recombination system. Specifically, the 
knock-out mutant of ptsG was constructed using the 
Red recombination system with pKD46 and pCP20 [28, 
29]. To increase the efficiency of homologous recombi-
nation, disruption cassettes with different priming sites 
(pFRT 4) were cloned and amplified using ptsG_del4_F 
and ptsG_del4_R, as described in our previous studies 
[3, 4]. In addition, the replacement of the native UTR of 
ptsG was performed using the scar-less recombineering 
method [30] with Red recombination and the rpsL-neo 
counterselection system according to the manufacturer’s 
instructions. For example, a mutation within the rpsL 
gene that confers a streptomycin-resistant phenotype 
was introduced using rpsL-A128G-oligo. The resulting 
JHL163 (rpsL*A128G) strain was subjected to the insertion 
of a rpsL-neo cassette upstream of the ptsG structural 
gene, exhibiting recessive sensitivity to streptomycin in a 
merodiploid (JHL110). Finally, oligo recombination using 
[ptsG_UTR(1 to 5)_oligo] that had distinctly redesigned 
5′-UTR sequences based on UTR Designer (http://sbi.
postech.ac.kr/utr_designer) [31] resulted in the ptsG 
UTR variants, UTR1, 2, 3, 4, and 5, without gaps (Fig. 2). 
The other strains were constructed in the same manner.
Media and growth conditions
Physiological analyses were conducted as follows: wild-
type E. coli was aerobically cultivated using M9 medium 
(6.78  g of  Na2HPO4, 3  g of  KH2PO4, 1  g of  NH4Cl, 
0.5 g of NaCl, 2 mL of 1 M  MgSO4, and 0.1 mL of 1 M 
WT 5′-CCCATACTCAGGAGCACTCTCAATT-ATG-3′
UTR1 5′-ATATTGAGAAGGACATCTCCTCGATAATG-3′
UTR2 5′-ATATTGAGAAGGAGATATCTCAATA-ATG-3′
UTR3 5′-ATATTGAGAAGGAGTTATCTCGATA-ATG-3′
UTR4 5′-ATAACGAGTAGGAGTTTCTCGATA- -ATG-3′
UTR5 5′-ACATTCACAAGGAGACGTCAACAATCATG-3′
 SgrS  3′-GGUUAUGAGUCAGUGUGU-ACUACG-UCC-5′
* *  * * * * * * * *   * * * *  * *   * * *
Fig. 2 Redesign of the 5′-UTR for ptsG based on base-pairs between 
SgrS and ptsG. The asterisks indicate the predicted base-pairing region 
of SgrS required for the translational repression of ptsG mRNA [24]. In 
particular, the minimal base-pairs for SgrS action for effective transla-
tional inhibition are shown in bold [26, 48]. The italic letters represent 
the Shine–Dalgarno (SD) sequence and the initiation codon for ptsG. 
The changed nucleotides with respect to the wild-type sequence of 
the ptsG UTR are underlined
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 CaCl2/L) supplemented with 40 g/L glucose [32]. Strep-
tomycin (25 μg/mL) was used to determine the genotype 
of rpsL*A128G. Overnight culture broths in LB medium 
were inoculated at approximately 1% into M9 culture 
medium and cultivated until reaching an optical density 
at 600 nm  (OD600) of ~0.8. The culture broths were inoc-
ulated at a final  OD600 of 0.05 in 25 mL of M9 medium 
in a 300-mL flask and incubated at 37  °C with shaking 
(250  rpm). The production of n-butanol was assayed 
using Terrific Broth (TB; 12 g of tryptone, 24 g of yeast 
extract, 2.31 g of  KH2PO4, 12.54 g of  K2HPO4, and 4 mL 
of glycerol per liter) supplemented with 25  g/L glucose. 
Multiple plasmids were maintained using 25 μg/mL spec-
tinomycin and 15  μg/mL kanamycin (pCDF-BuOH and 
pCOLA-F5). Rubber-sealed, 60-mL serum bottles were 
used for anaerobic cultures using an anaerobic chamber 
(Coy Laboratories, Ann Arbor, MI, USA). Overnight cul-
ture broths in LB medium were inoculated into 20 mL of 
fresh TB medium at a final  OD600 of 0.05 and incubated 
anaerobically at 37  °C in a rotary shaker (250  rpm) [3]. 
The production of butyric acid was assayed using Terrific 
Broth (TB; 12 g of tryptone, 24 g of yeast extract, 2.31 g 
of  KH2PO4, 12.54 g of  K2HPO4, excluding glycerol) sup-
plemented with 10  g/L glucose. The plasmid (pBASP) 
was maintained by including 34  μg/mL chlorampheni-
col. Rubber-sealed, 60-mL serum bottles were used for 
anaerobic cultures using an anaerobic chamber (Coy 
Laboratories). Overnight culture broths in LB medium 
were inoculated into 20 mL of fresh TB medium at a final 
 OD600 of 0.05 and incubated anaerobically at 37  °C in a 
rotary shaker (250 rpm) [4]. The production of 2,3-butan-
ediol was tested using M9 medium (6.78 g of  Na2HPO4, 
3 g of  KH2PO4, 1 g of  NH4Cl, 0.5 g of NaCl, 2 mL of 1 M 
 MgSO4, and 0.1 mL of 1 M  CaCl2/L) supplemented with 
40 g/L glucose and 5 g/L yeast extract. The plasmid (pZS-
budABC) was maintained by including 30  μg/mL kana-
mycin. Overnight culture broths in culture medium were 
inoculated into 100 mL of modified M9 medium at a final 
 OD600 of 0.05 and incubated at 37  °C in a rotary shaker 
(180 rpm) under micro-aerobic condition. The anhydro-
tetracycline was added to a final concentration of 100 ng/
mL when the  OD600 reached approximately 0.5 [5]. Theo-
retical yield was determined on the basis of pathway stoi-
chiometry, e.g., 1 mol of n-butanol per 1 mol of glucose.
Analytical methods
The concentrations of glucose, organic acids, and alco-
hols were determined using high-performance liquid 
chromatography (UltiMate 3000 Analytical HPLC Sys-
tem; Dionex, Sunnyvale, CA, USA) with an Aminex 
HPX-87H Column (Bio-Rad Laboratories, Richmond, 
CA, USA) using 5 mM  H2SO4 as the mobile phase. The 
2,3-butanediol samples were analyzed at a flow rate of 
0.5 mL/min at 65 °C and otherwise a flow rate of 0.6 mL/
min at 14 °C was used to quantify metabolites. The signal 
was monitored using a UV–Vis diode array detector (at 
210 nm) and a Shodex RI-101 detector (Shodex, Klokker-
faldet, Denmark).
Glucose uptake rate
The specific glucose uptake rate was determined as 
growth rate divided by biomass yield during exponential 
growth as previously described [33]. One  OD600 unit cor-
responds to 0.25 g dry cell weight (DCW)/L [34]. Instead, 
glucose consumption rate, determined as the analytic 
data from HPLC during the initial exponential phase, 
was represented for the production systems as the com-
ponents in the TB medium also contributed to biomass 
yield.
Results
Tuning glycolytic activity through UTR engineering of ptsG
We initially redesigned five 5′-UTR variants to control 
ptsG activity as well as to deregulate translational repres-
sion [27] by the bacterial small RNA SgrS (which medi-
ates phosphosugar stress responses) by modifying the 
minimal base-pairing region essential for SgrS action [26] 
(Fig. 2). As shown in Fig. 3b, seven strains with UTR vari-
ants, including positive  (UTRWT) and negative (∆ptsG) 
control strains, showed the various specific glucose 
uptake rates that were highly correlated with specific 
growth rates (R2 = 0.89) in the minimal medium. These 
results agree with previous continuous culture data indi-
cating that the specific glucose uptake rate increases 
linearly as a function of the dilution or growth rate [33, 
35]. Moreover, differences in the glucose consumption 
rate were also related to the accumulation of acetate 
(R2 = 0.88) and pyruvate (R2 = 0.77) (Fig. 3a, c, d). As the 
secretion of acetate and pyruvate is generally considered 
to result from a higher carbon flux than the flux through 
the TCA cycle, which is required for both biosynthesis 
and energy production (Fig.  3a) [10, 36], the accumula-
tion of acetate and pyruvate as natural by-products in 
wild-type E. coli collectively represents glycolytic activ-
ity. Consequently, our results show that UTR engineering 
of ptsG could successfully modulate overall PTS activity 
(represented as the glucose uptake rate) and glycolytic 
flux.
Interestingly, the redesign of the upstream region 
of ptsG enabled a higher specific glucose uptake rate 
(+20.8%), probably due to the deregulation of SgrS 
action, and subsequently led to a higher growth rate 
(+7.3%) and higher accumulation of acetate (+13.9%) 
and pyruvate (+11.0%) than those of the parental strain 
(Fig. 3b–d). These results indicate that the glucose trans-
porter (encoded by ptsG) can amplify glycolytic flux as a 
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preliminary rate-determining step, even in the presence 
of complex regulatory mechanisms for other glycolytic 
enzymes [14].
Leak‑free pathway engineering to improve n‑butanol cell 
factory yield
The n-butanol synthetic pathway was selected as an 
example in which glycolytic activity was higher than 
product formation under anaerobic condition. Previ-
ously, many studies have attempted to optimize the 
n-butanol production pathway, but substantial levels of 
pyruvate accumulated as a by-product in the medium, 
indicating the n-butanol synthesis pathways are still 
inefficient [3, 37, 38]. Therefore, in this case, tuning down 
of glycolytic flux is an effective way to minimize wasteful 
pyruvate production, which decreases yield (Fig. 4a).
We used an approach that we termed leak-free path-
way engineering to improve the yield of the n-butanol 
cell factory. Seven ptsG UTR variants, including the 
native sequence (JHL 178–183), were engineered using 
n-butanol-producing E. coli JHL 59 (ΔatoDA ΔadhE 
ΔldhA ΔpaaFGH ΔfrdABCD Δpta  PatoB::BBa_J23100 
 Plpd::BBa_J23100 lpd(G1060A)  PaceEF::BBa_J23100) as 
the parental strain [3]. After a 24-h fermentation period, 
each variant showed different physiological results in 
terms of the accumulation of biomass, n-butanol, and 
0.40
0.45
0.50
0.55
0.60
= 0.89
UTR 5
UTR 1
UTR 4
UTR 3
UTR 2
∆ ptsG
UTRWT
Ac
et
at
e 
(m
M
)
4
5
6
7
8
9
10
R2 = 0.88
20 25 30 35 40
20 25 30 35 40 20 25 30 35 40
Py
ru
va
te
 (m
M
)
2
4
6
8
10
12
14
R2 = 0.77
ba
dc
GLC
PYR
AcCoA
Biosynthesis
CO2
PYRext
Acetate
TCA
Specific glucose uptake rate (mmol g DCW -1 h-1)
Specific glucose uptake rate (mmol g DCW -1 h-1) Specific glucose uptake rate (mmol g DCW -1 h-1)
Sp
ec
ifi
c 
gr
ow
th
 ra
te
 (h
-1
)
R2
UTR 5
UTR 1
UTR 4UTR 3
UTR 2
∆ ptsG
UTRWTUTR 5
UTR 1
UTR 4
UTR 3
UTR 2
∆ ptsG
UTRWT
Fig. 3 Physiological comparison among ptsG variants of wild-type E. coli W3110. a Schematic metabolic pathway for wild-type E. coli. The dotted red 
and blue arrows indicate glycolytic flux control and the corresponding change in flux for two natural metabolites, respectively. b Specific growth 
rate, c acetate, and d pyruvate are represented as a function of the specific glucose uptake rate. The specific glucose uptake rate was determined as 
growth rate divided by biomass yield during exponential growth as previously described [33]. One  OD600 unit corresponds to 0.25 g dry cell weight 
(DCW)/L. The error bars indicate standard deviations of measurements from two independent cultures
Page 6 of 10Lim and Jung  Biotechnol Biofuels  (2017) 10:160 
pyruvate as well as glucose consumption (Fig. 4b). Along 
with the decrease in the glucose consumption rate, 99% 
of pyruvate secretion was successfully eliminated, from 
43.92  mM in UTR5 (JHL179) to 0.50  mM in ∆ptsG 
(JHL184), by glycolytic flux modulation, and there was 
a strong correlation between pyruvate secretion and the 
glucose consumption rate (R2 = 0.98) (Fig. 4c). The final 
titer of n-butanol decreased from 69.88  mM  (UTRWT, 
JHL178) to 54.54 mM (∆ptsG, JHL184) (Fig. 4b). In addi-
tion, the specific growth rate showed strong correlations 
between the glucose consumption rate (R2  =  0.93) and 
the specific glucose uptake rate (R2 = 0.94), even in rich 
TB medium (Additional file  1: Figures  S1, S2, respec-
tively). These results indicate that controlling the ptsG 
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expression level through UTR engineering could success-
fully modulate the glycolytic flux of the engineered strain, 
even under anaerobic conditions.
To evaluate cellular performance in n-butanol pro-
duction, yield and productivity were examined (Fig. 4d). 
Notably, n-butanol yield increased as glycolytic flux 
decreased, which was attributed to a reduction in pyru-
vate leakage (Fig. 4c), but only slight changes in produc-
tivity were observed. This clearly shows that reducing 
glycolytic flux by modifying the glucose uptake rate had 
a greater influence on pyruvate secretion than n-butanol 
production. Among the tested variants, the JHL181 
strain with the UTR3 variant indicated the optimal glyco-
lytic flux for the best trade-off between yield and produc-
tivity as it showed 84% of the theoretical maximum yield 
by a 20% improvement (0.84  mol butanol/mol glucose) 
compared to the parental strain, but exhibited negligible 
changes in productivity (2.90 mM butanol L/h for UTR3 
vs. 2.91  mM butanol  L/h for  UTRWT) (Fig.  4d). Under 
the level of UTR3, however, n-butanol productivity 
decreased as a function of the glucose uptake rate, even 
though the yield increased to 93% of the theoretical max-
imum (Please see UTR2 in Fig.  4d). This indicates that 
glycolytic flux with UTR3 corresponds to the capacity of 
the engineered n-butanol synthesis pathway and glyco-
lytic fluxes below this level can be regarded as the rate-
limiting step for the production of n-butanol (Fig.  4d). 
The JHL179 strain with the UTR5 variant, whose rate 
of glucose uptake was higher (+18.34%) than that of the 
parental strain, showed substantial reductions in yield as 
well as productivity owing to a significant decrease in pH 
resulting from acidic pyruvate accumulation (+42.65% 
compared to  UTRWT; Fig. 4c), which negatively affected 
glucose consumption (Fig.  4b). Taken together, our 
results demonstrate that yield can be maximized while 
maintaining maximum productivity simply by optimizing 
the glycolytic flux according to the capacity of the prod-
uct formation pathways via fine-control of ptsG.
Improvement in productivity by enhanced glycolytic 
activity through UTR engineering of ptsG
In general, product yield can be maximized via the dele-
tion of pathways for unnecessary by-product formation, 
but increasing productivity beyond this maximized yield 
is challenging [7]. Nevertheless, further increases in pro-
ductivity, while maintaining the maximum yield can be 
expected by enhancing the glycolytic flux if the capacity 
of the product formation pathway is higher than the nat-
ural glycolytic activity.
To verify this, previously engineered E. coli strains 
for the production of butyrate [4] and 2,3-butanediol 
[5] were exploited as model systems; their product 
yields were close to the theoretical maximum due to the 
elimination of native by-product formation pathways, 
such as lactate and ethanol. Since butyrate is a fermen-
tative product, energy for biosynthesis is mostly gener-
ated by the butyrate production pathway under anaerobic 
conditions, and the engineered strain JHL265 showed 
83.4% of the theoretical maximum yield (Fig.  5a) [4]. 
However, the biological conversion rate of 2,3-butan-
ediol from pyruvate could be maximized in the presence 
of oxygen and therefore a portion of the carbon source 
should be consumed to generate energy by conversion to 
carbon dioxide (Fig. 5b) [39].
To enhance glycolytic activity, ptsG expression was 
activated using UTR5 (resulting JHL266). As expected, 
the amplified glucose consumption rate translated to 7% 
higher productivity for butyrate (1.45 mmol butyrate L/h) 
than the parental strain, while the yield was maintained at 
approximately 83% of theoretical maximum (Fig. 5c). In 
the case of 2,3-butanediol production, the productivity of 
the strain with higher glycolytic activity (UTR5), result-
ing JHL268, could be improved by 12.45% compared 
to the parental strain JHL267 (2.38  mmol 2,3-butan-
ediol  L/h), while maintaining the parental maximum 
yield (approximately 60% of the theoretical maximum), as 
shown in Fig. 5d. Our results clearly show that the pro-
ductivity of biological processes could be improved by 
amplifying glycolysis per se through UTR engineering of 
ptsG.
Discussion
Although the entire pathway from sugar uptake to prod-
uct formation has to be well-balanced for optimal yield 
and productivity, research in metabolic engineering has 
focused on production pathways. Furthermore, con-
trolling glycolytic flux remains a daunting task owing 
to incomplete knowledge of the mechanisms that regu-
late glycolysis [14]. While many process control tech-
niques, such as carbon limited fed-batch cultivation, are 
the standard approaches to control overflow metabo-
lism [40], our approach has the advantage of increasing 
robustness of biological production by optimizing glyco-
lytic flux at the genetic level.
In this study, we demonstrated the physiological rel-
evance of ptsG to overall glycolytic activity as the sim-
ple method for the control of metabolic input. As small 
RNA SgrS inherently represses the translation of ptsG 
mRNA by sequestering its ribosome binding site and 
RNaseE-dependent cleavage through a short base-pair-
ing interaction [21, 22], the glucose transporter encoded 
by ptsG was modulated using synthetic 5′-UTRs for the 
fine-control of translation efficiency in addition to the 
deregulation of SgrS. Although the molecular study for 
the UTR engineering-mediated mitigation of SgrS regu-
lation should be further investigated, our physiological 
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results successfully demonstrate the ability to control the 
glycolytic flux through ptsG as shown in Fig. 3. Moreo-
ver, the redesign of native UTR for allowed an increase in 
glycolytic flux by 20.8% compared to the wild type, even 
though none of the overexpressed glycolytic enzymes 
increased glycolytic activity in previous studies [41–43]. 
Since native glycolytic activity is often not sufficient for 
non-native product formation pathways and therefore 
increased glycolytic activity is necessary to maximize the 
rate of product formation for industrial applications, the 
observation that ptsG might be a preliminary rate-deter-
mining step in glycolysis is also intriguing.
Using these findings, the optimal glycolytic flux was 
explored with respect to the capacity of the n-butanol, 
butyrate, and 2,3-butanediol synthesis pathways to 
improve cellular performance. Interestingly, the yield 
of n-butanol increased to 93% of the theoretical maxi-
mum due to a reduction in pyruvate secretion in accord-
ance with tuning down of the glycolytic flux. Conversely, 
enhanced productivity was observed for the production 
of butyrate and 2,3-butanediol by activating the expres-
sion level of ptsG (via UTR5). Collectively, these results 
clearly indicate that optimization of the glycolytic flux 
enables additional improvements in both yield and pro-
ductivity of cell factories, beyond optimization of the 
product formation pathway.
The concept of optimizing glycolytic flux is also impor-
tant to the microbial production of various chemicals 
and fuels from cost-effective feedstock, such as glycerol 
[44] and galactose [45] and our strategy can be applied to 
explore optimal glycolytic flux depending on the capacity 
of product formation pathway via fine-control of glycerol 
a b
dc
1.2
1.3
1.4
1.5
1.6
0
20
40
60
80
100
UTRWT
(JHL265)
2.0
2.1
2.2
2.3
2.4
2.5
Yield to theoretical m
axim
um
 (%
)
0
20
40
60
80
100
Pr
od
uc
tiv
ity
 o
f b
ut
yr
ic 
ac
id
 (m
m
ol
 L
-1
 h
-1
) 
Pr
od
uc
tiv
ity
 o
f 2
,3
-b
ut
an
ed
io
l (
m
m
ol
 L
-1
 h
-1
) 
Yield to theoretical m
axim
um
 (%
)
UTR5
(JHL266)
UTRWT
(JHL267)
UTR5
(JHL268)
Controlling flux
Glycolysis Product formation pathway
GLC
PYR AcCoA Butyrate
Controlling flux
Glycolysis
Product formation pathway
TCA cycle
GLC
PYR AcCoA
2,3-Butanediol
TCA
CO2
Fig. 5 Comparative analysis of UTR5 to improve the productivity of butyrate and 2,3-butanediol. a Schematic metabolic pathway for the produc-
tion of a butyrate and b 2,3-butanediol. The flux for the TCA cycle was included in the 2,3-butanediol system due to the presence of oxygen. The 
dotted red and blue arrows indicate controlled glycolytic flux and additional carbon flux from glycolysis to the product-forming pathway, respec-
tively (dotted black outer lines). c The productivity (red) and yield (blue) of butyrate were compared after 24 h of fermentation in TB medium. d The 
productivity (red) and yield (blue) of 2,3-butanediol were calculated after 39 h of cultivation in modified M9 medium. The error bars indicate standard 
deviations of measurements from two independent cultures
Page 9 of 10Lim and Jung  Biotechnol Biofuels  (2017) 10:160 
transporter (encoded by glpF) [46] and galactose trans-
porter (encoded by galP) [47], respectively. Ultimately, 
as summarized in Fig. 6, balanced pathway amplification 
of both glycolytic flux and product-forming pathways 
are highly desirable for the design of economically fea-
sible microbial cell factories in the bio-based chemical 
industry.
Conclusions
In this study, we examined the metabolic imbalance 
between glycolysis and product formation pathways 
using recombinant Escherichia coli strains producing 
n-butanol, butyrate, or 2,3-butanediol as model cell fac-
tories. Initially, the glucose uptake rate of wild-type E. 
coli was fine-tuned using synthetic UTRs of ptsG to mod-
ulate the overall glycolytic fluxes, which were assessed 
by physiological parameters, i.e., specific growth rate 
and the accumulation of acetate and pyruvate as natural 
by-products. Moving forward, glycolytic flux was rebal-
anced via the control of ptsG depending on the efficiency 
of product formation pathways with lower (n-butanol) 
and higher (butyrate and 2,3-butanediol) product for-
mation capacities compared to the wild-type glycolytic 
flux. For the production of n-butanol, glycolytic flux suc-
cessfully tuned down to minimize by-product formation, 
while maintaining productivity, which we termed leak-
free pathway engineering. Conversely, butyrate and 
2,3-butanediol production rates were increased using a 
UTR variant of ptsG with higher glycolytic flux than that 
of the wild type. These results demonstrate the simple 
method to control glycolytic flux for the design of opti-
mal cell factories in the fields of metabolic engineering 
and synthetic biology.
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